Polyarteritis Nodosa and Associated Antibodies

Polyarteritis nodosa (PAN) is a type of vasculitis that affects medium-sized arteries, particularly those in the renal vasculature. Patients with PAN may experience vague symptoms such as malaise, weight loss, anemia, fever, and non-specific pains. However, more specific features of PAN include acute renal failure with beading of the renal vessel on angiography, livedo reticularis, the presence of pANCA in the blood, and granulomas with eosinophilic infiltrate on biopsy. While the majority of PAN cases are idiopathic, it can also be associated with hepatitis B virus infection.

In addition to PAN, there are other autoimmune or inflammatory conditions that may be associated with specific antibodies. For example, anti-mitochondrial antibody (AMA) is strongly associated with primary biliary cirrhosis, while Antinuclear antibodies (ANA) are non-specific and may be present in conditions such as SLE, autoimmune hepatitis, post-infection, and inflammatory bowel disease. Therefore, the presence of certain antibodies can aid in the diagnosis and management of these conditions.

Transfusion of packed red cells is frequently associated with pyrexia as an adverse event, while infusion of FFP often leads to urticaria as the most common adverse event.

Blood product transfusion complications can be categorized into immunological, infective, and other complications. Immunological complications include acute haemolytic reactions, non-haemolytic febrile reactions, and allergic/anaphylaxis reactions. Infective complications may arise due to transmission of vCJD, although measures have been taken to minimize this risk. Other complications include transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), hyperkalaemia, iron overload, and clotting.

Non-haemolytic febrile reactions are thought to be caused by antibodies reacting with white cell fragments in the blood product and cytokines that have leaked from the blood cell during storage. These reactions may occur in 1-2% of red cell transfusions and 10-30% of platelet transfusions. Minor allergic reactions may also occur due to foreign plasma proteins, while anaphylaxis may be caused by patients with IgA deficiency who have anti-IgA antibodies.

Acute haemolytic transfusion reaction is a serious complication that results from a mismatch of blood group (ABO) which causes massive intravascular haemolysis. Symptoms begin minutes after the transfusion is started and include a fever, abdominal and chest pain, agitation, and hypotension. Treatment should include immediate transfusion termination, generous fluid resuscitation with saline solution, and informing the lab. Complications include disseminated intravascular coagulation and renal failure.

TRALI is a rare but potentially fatal complication of blood transfusion that is characterized by the development of hypoxaemia/acute respiratory distress syndrome within 6 hours of transfusion. On the other hand, TACO is a relatively common reaction due to fluid overload resulting in pulmonary oedema. As well as features of pulmonary oedema, the patient may also be hypertensive, a key difference from patients with TRALI.

Subarachnoid haemorrhage is characterised by a sudden occipital headache, often described as the worst headache of the patient’s life. It is commonly caused by the rupture of a cerebral aneurysm and is associated with hypertension, smoking, and autosomal dominant polycystic kidney disease. Symptoms may also include photophobia and neck stiffness. Bacterial meningitis, extradural haematoma, and intracerebral haematoma are incorrect answers as they present with different symptoms and causes.

There are different types of traumatic brain injury, including focal (contusion/haematoma) or diffuse (diffuse axonal injury). Diffuse axonal injury occurs due to mechanical shearing following deceleration, causing disruption and tearing of axons. Intracranial haematomas can be extradural, subdural or intracerebral, while contusions may occur adjacent to (coup) or contralateral (contre-coup) to the side of impact. Secondary brain injury occurs when cerebral oedema, ischaemia, infection, tonsillar or tentorial herniation exacerbates the original injury.

Alzheimer’s disease is characterized by the presence of cortical plaques, which are caused by the deposition of type A-Beta-amyloid protein, and intraneuronal neurofibrillary tangles, which are caused by abnormal aggregation of the tau protein.

Tau proteins are abundant in the CNS and play a role in stabilizing microtubules. When they become defective, they accumulate as hyperphosphorylated tau and form paired helical filaments that aggregate inside nerve cell bodies as neurofibrillary tangles.

Amyloid precursor protein (APP) is an integral membrane protein that is expressed in many tissues and concentrated in the synapses of neurons. While its primary function is not known, it has been implicated as a regulator of synaptic formation, neural plasticity, and iron export. APP is best known as a precursor molecule, and proteolysis generates beta amyloid, which is the primary component of amyloid plaques found in the brains of Alzheimer’s disease.

Although Ach receptors are reduced in Alzheimer’s disease, they are not visible on histology.

Alzheimer’s disease is a type of dementia that gradually worsens over time and is caused by the degeneration of the brain. There are several risk factors associated with Alzheimer’s disease, including increasing age, family history, and certain genetic mutations. The disease is also more common in individuals of Caucasian ethnicity and those with Down’s syndrome.

The pathological changes associated with Alzheimer’s disease include widespread cerebral atrophy, particularly in the cortex and hippocampus. Microscopically, there are cortical plaques caused by the deposition of type A-Beta-amyloid protein and intraneuronal neurofibrillary tangles caused by abnormal aggregation of the tau protein. The hyperphosphorylation of the tau protein has been linked to Alzheimer’s disease. Additionally, there is a deficit of acetylcholine due to damage to an ascending forebrain projection.

Neurofibrillary tangles are a hallmark of Alzheimer’s disease and are partly made from a protein called tau. Tau is a protein that interacts with tubulin to stabilize microtubules and promote tubulin assembly into microtubules. In Alzheimer’s disease, tau proteins are excessively phosphorylated, impairing their function.

Surface Anatomy of the Neck: Identifying Structures and Corresponding Levels

The neck is a complex region of the body that contains numerous structures and landmarks. By understanding the surface anatomy of the neck, healthcare professionals can accurately identify and locate important structures during physical examinations and medical procedures.

In the midline of the neck, several structures can be felt from top to bottom. These include the hyoid at the level of C3, the notch of the thyroid cartilage at C4, and the cricoid cartilage at C6. The lower border of the cricoid cartilage is particularly significant as it corresponds to several important structures, including the junction of the larynx and trachea, the junction of the pharynx and esophagus, and the level at which the inferior thyroid artery enters the thyroid gland. Additionally, the vertebral artery enters the transverse foramen in the 6th cervical vertebrae at this level, and the superior belly of the omohyoid muscle crosses the carotid sheath. The middle cervical sympathetic ganglion is also located at this level, as well as the carotid tubercle, which can be used to compress the carotid artery.

Overall, understanding the surface anatomy of the neck is crucial for healthcare professionals to accurately identify and locate important structures during physical examinations and medical procedures.

Abdominal pain can be an initial symptom of DKA, which is the most probable diagnosis in this case. The patient’s symptoms, including abdominal pain, strongly suggest DKA. Blood ketones are the appropriate investigation as they are part of the diagnostic criteria for DKA, along with pH and bicarbonate.

Amylase could help rule out acute pancreatitis, but it is not the most likely diagnosis, so it would not confirm it. Pancreatitis typically presents with severe upper abdominal pain and vomiting. Polydipsia and polyuria are more indicative of DKA, and the patient’s known history of type 1 diabetes mellitus makes DKA more likely.

Beta-hCG would be an appropriate investigation for abdominal pain in a woman of childbearing age, but it is not necessary in this case as DKA is the most likely diagnosis.

Blood glucose levels would be useful if the patient were not a known type 1 diabetic, but they do not form part of the diagnostic criteria for DKA. Blood glucose levels would also be helpful in distinguishing between DKA and HHS, but HHS is unlikely in this case as it occurs in patients with type 2 diabetes.

Diabetic ketoacidosis (DKA) is a serious complication of type 1 diabetes mellitus, accounting for around 6% of cases. It can also occur in rare cases of extreme stress in patients with type 2 diabetes mellitus. DKA is caused by uncontrolled lipolysis, resulting in an excess of free fatty acids that are converted to ketone bodies. The most common precipitating factors of DKA are infection, missed insulin doses, and myocardial infarction. Symptoms include abdominal pain, polyuria, polydipsia, dehydration, Kussmaul respiration, and breath that smells like acetone. Diagnostic criteria include glucose levels above 11 mmol/l or known diabetes mellitus, pH below 7.3, bicarbonate below 15 mmol/l, and ketones above 3 mmol/l or urine ketones ++ on dipstick.

Management of DKA involves fluid replacement, insulin, and correction of electrolyte disturbance. Fluid replacement is necessary as most patients with DKA are deplete around 5-8 litres. Isotonic saline is used initially, even if the patient is severely acidotic. Insulin is administered through an intravenous infusion, and correction of electrolyte disturbance is necessary. Long-acting insulin should be continued, while short-acting insulin should be stopped. Complications may occur from DKA itself or the treatment, such as gastric stasis, thromboembolism, arrhythmias, acute respiratory distress syndrome, acute kidney injury, and cerebral edema. Children and young adults are particularly vulnerable to cerebral edema following fluid resuscitation in DKA and often need 1:1 nursing to monitor neuro-observations, headache, irritability, visual disturbance, focal neurology, etc.

The binding of tau to microtubules is negatively regulated by phosphorylation. In a healthy adult brain, tau promotes the assembly of microtubules, but in Alzheimer’s disease, hyperphosphorylation of tau inhibits its ability to bind to microtubules normally. This leads to the formation of neurofibrillary tangles instead of promoting microtubule assembly. It is important to note that tau is not a product of Alzheimer’s disease pathology, but rather a physiological protein that becomes involved in the pathophysiological process. Additionally, amyloid beta and tau are not phosphorylated together to form a tangle, and tau does not become bound to microtubules by amyloid beta to form plaques. Lastly, in Alzheimer’s disease, tau is hyperphosphorylated, not inadequately phosphorylated.

Alzheimer’s disease is a type of dementia that gradually worsens over time and is caused by the degeneration of the brain. There are several risk factors associated with Alzheimer’s disease, including increasing age, family history, and certain genetic mutations. The disease is also more common in individuals of Caucasian ethnicity and those with Down’s syndrome.

The pathological changes associated with Alzheimer’s disease include widespread cerebral atrophy, particularly in the cortex and hippocampus. Microscopically, there are cortical plaques caused by the deposition of type A-Beta-amyloid protein and intraneuronal neurofibrillary tangles caused by abnormal aggregation of the tau protein. The hyperphosphorylation of the tau protein has been linked to Alzheimer’s disease. Additionally, there is a deficit of acetylcholine due to damage to an ascending forebrain projection.

Neurofibrillary tangles are a hallmark of Alzheimer’s disease and are partly made from a protein called tau. Tau is a protein that interacts with tubulin to stabilize microtubules and promote tubulin assembly into microtubules. In Alzheimer’s disease, tau proteins are excessively phosphorylated, impairing their function.

Losing 500ml of fluid (for a 70 Kg male) is typically enough to trigger the renin angiotensin system, but it is unlikely to cause any other bodily disruptions.

Understanding Bleeding and its Effects on the Body

Bleeding, even if it is of a small volume, triggers a response in the body that causes generalised splanchnic vasoconstriction. This response is mediated by the activation of the sympathetic nervous system. The process of vasoconstriction is usually enough to maintain renal perfusion and cardiac output if the volume of blood lost is small. However, if greater volumes of blood are lost, the renin angiotensin system is activated, resulting in haemorrhagic shock.

The body’s physiological measures can restore circulating volume if the source of bleeding ceases. Ongoing bleeding, on the other hand, will result in haemorrhagic shock. Blood loss is typically quantified by the degree of shock produced, which is determined by parameters such as blood loss volume, pulse rate, blood pressure, respiratory rate, urine output, and symptoms. Understanding the effects of bleeding on the body is crucial in managing and treating patients who experience blood loss.

Metformin activates the AMP-activated protein kinase (AMPK) to improve insulin response and glucose uptake. GLP1 agonists enhance insulin release and reduce glucagon release by binding to GLP-1 receptors in the pancreas. Sulfonylureas close ATP-sensitive potassium (K-ATP) channels on pancreatic beta cells, leading to depolarization. Thiazolidinediones bind to peroxisome proliferator-activated receptor-gamma in adipocytes to promote adipogenesis and fatty acid uptake in peripheral fat. DPP-4 inhibitors block the action of DPP-4, which destroys incretin, a hormone that helps the body produce more insulin when needed and reduce glucose production by the liver when not needed.

Metformin is a medication commonly used to treat type 2 diabetes mellitus, as well as polycystic ovarian syndrome and non-alcoholic fatty liver disease. Unlike other medications, such as sulphonylureas, metformin does not cause hypoglycaemia or weight gain, making it a first-line treatment option, especially for overweight patients. Its mechanism of action involves activating the AMP-activated protein kinase, increasing insulin sensitivity, decreasing hepatic gluconeogenesis, and potentially reducing gastrointestinal absorption of carbohydrates. However, metformin can cause gastrointestinal upsets, reduced vitamin B12 absorption, and in rare cases, lactic acidosis, particularly in patients with severe liver disease or renal failure. It is contraindicated in patients with chronic kidney disease, recent myocardial infarction, sepsis, acute kidney injury, severe dehydration, and those undergoing iodine-containing x-ray contrast media procedures. When starting metformin, it should be titrated up slowly to reduce the incidence of gastrointestinal side-effects, and modified-release metformin can be considered for patients who experience unacceptable side-effects.

Understanding Erythrocyte Sedimentation Rate (ESR)

The Erythrocyte Sedimentation Rate (ESR) is a test that measures the rate at which red blood cells settle in a tube over a period of time. It is a non-specific marker of inflammation and can be affected by various factors such as the size, shape, and number of red blood cells, as well as the concentration of plasma proteins like fibrinogen, alpha2-globulins, and gamma globulins.

A high ESR can be caused by various conditions such as temporal arteritis, myeloma, connective tissue disorders like systemic lupus erythematosus, malignancies, infections, and other factors like increasing age, female sex, and anaemia. On the other hand, a low ESR can be caused by conditions like polycythaemia, afibrinogenaemia, or hypofibrinogenaemia.

It is important to note that while a high ESR can indicate the presence of an underlying condition, it is not a definitive diagnosis and further testing may be required to determine the cause. Therefore, it is essential to consult a healthcare professional for proper evaluation and management.